Smokeless TobaccoAddictionMental healthBehavioral
What this study is
This study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.
What's being tested
- Copenhagen group
Intervention · OTHER
- Snus group
Intervention · OTHER
Both interventions
Participants use product for up to 30 minutes
Study details
- Sponsor
- Roswell Park Cancer Institute
- Conditions
- Smokeless Tobacco
- Enrolling
- 50 people
- Starts
- 2026-05-11
- Est. completion
- 2027-05-01
- Design
- Open-label, randomized, factorial
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 21 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Age ≥ 21 years of age
- Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming)
- Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year
- Open to trying a non-combusted oral tobacco product
- Have the ability to read, write, and communicate in English
- Have successfully completed our preliminary Auction study I-4008824 with a bid for Copenhagen and/or General Snus > $0
- Willing to abstain smoking 8-10 hours prior to each laboratory session and complete breath CO test for verification (<8ppm)
- Female participants must be amenable to taking a pregnancy test (urine) prior to beginning study procedures.
- Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure.
You can't join if
- Age ≥ 21 years of age
- Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming)
- Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year
- Open to trying a non-combusted oral tobacco product
- Have the ability to read, write, and communicate in English
- Have successfully completed our preliminary Auction study I-4008824 with a bid for Copenhagen and/or General Snus > $0
- Willing to abstain smoking 8-10 hours prior to each laboratory session and complete breath CO test for verification (<8ppm) .
- Female participants must be amenable to taking a pregnancy test (urine) prior to beginning study procedures.
- Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openRoswell Park
Buffalo, New York, United States
- ask rpci · Contact877-275-7724askrpci@roswellpark.org
- Richard O'Connor, PHD · Principal investigator
Recruiting
Study team
Sponsor
Roswell Park Cancer Institute
Study ID I-4008824-1
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.